November 15, 2002
Rethinking Protections for Human Subjects
Has the pendulum swung too far in the application of human-subject protections to scholarly research? Several well-publicized deaths -- including that of Jesse Gelsinger, an 18-year-old who died during a gene-therapy experiment -- in clinical trials, along with scientific advances in cloning, human genetics, and stem-cell research, have led to heightened scrutiny of academic research by the government and the news media. As a result, some universities have become hypercautious about
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
